Table 3.

Recovery of CFSE- and PKH-labeled donor cells in peritoneum of thioglycollate-elicited recipients




Donor CFSE/PKH

Recovered CFSE/PKH
ΔP1-CFSE/ΔP1-PKH donor   
    ΔP1 recipient 1   1.30   1.3  
    ΔP1 recipient 2   1.30   1.3  
ΔP1-CFSE/WT-PKH donor   
    WT recipient 1   1.24   1.3  
    WT recipient 2   1.24   1.2  
    WT recipient 3   1.24   1.2  
    WT recipient 4   1.24   1.0  
    ΔP1 recipient 1   1.24   0.8  
    ΔP1 recipient 2   1.24   1.2  
    ΔP1 recipient 3   1.24   1.2  
    ΔP1 recipient 4
 
1.24
 
1.2
 



Donor CFSE/PKH

Recovered CFSE/PKH
ΔP1-CFSE/ΔP1-PKH donor   
    ΔP1 recipient 1   1.30   1.3  
    ΔP1 recipient 2   1.30   1.3  
ΔP1-CFSE/WT-PKH donor   
    WT recipient 1   1.24   1.3  
    WT recipient 2   1.24   1.2  
    WT recipient 3   1.24   1.2  
    WT recipient 4   1.24   1.0  
    ΔP1 recipient 1   1.24   0.8  
    ΔP1 recipient 2   1.24   1.2  
    ΔP1 recipient 3   1.24   1.2  
    ΔP1 recipient 4
 
1.24
 
1.2
 

Total bone marrow cells from donors labeled with CFSE of PKH-26 were pooled and injected into tail veins of recipient animals. At the same time, 1 mL of 4% wt/vol thioglycollate was introduced intraperitoneally into recipients. After 6 hours, peritoneal aspirate was recovered from recipients and examined by flow cytometry.

or Create an Account

Close Modal
Close Modal